Book Cover
Home  |   Healthcare   |  IV Equipment Market

IV Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Infusion Pump, Catheter, Solution and Blood Administration Set), By Application (Hospitals & Clinics, Homecare, Ambulatory Care Center), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

IV Equipment Market Overview

IV Equipment Market size is estimated at USD 17535.31 million in 2026 and expected to rise to USD 28562.18 million by 2035, experiencing a CAGR of 5.57%.

The IV Equipment Market continues to expand due to increasing hospital admissions, rising prevalence of chronic diseases, growing surgical procedures, and higher demand for safe intravenous drug administration. More than 74% of hospitalized patients receive intravenous therapy during treatment, while approximately 69% of healthcare facilities continue investing in advanced infusion technologies to improve patient safety and treatment accuracy. Increasing adoption of smart infusion pumps, needle-free connectors, and advanced catheter systems continues supporting market expansion across hospitals, ambulatory care centers, and home healthcare services worldwide.

The United States remains one of the leading markets for IV Equipment due to advanced healthcare infrastructure, increasing chronic disease management, and widespread adoption of smart infusion technologies. More than 72% of acute care hospitals utilize advanced infusion pumps integrated with electronic medical record systems to improve medication safety. Approximately 65% of healthcare providers continue upgrading intravenous therapy equipment to enhance treatment efficiency, infection control, and patient monitoring. Continuous investment in healthcare modernization continues supporting market growth throughout the country.

The IV Equipment Market continues to experience steady growth as healthcare providers focus on improving patient safety, treatment accuracy, and operational efficiency. Approximately 73% of hospitals continue investing in advanced intravenous therapy systems equipped with smart monitoring, automated dose control, and wireless connectivity. Around 67% of healthcare facilities are replacing conventional IV devices with intelligent infusion pumps and safety-engineered administration sets to reduce medication errors and infection risks. Increasing demand for home healthcare, ambulatory treatment, and digital healthcare solutions continues creating growth opportunities. Continuous innovation in portable infusion systems, antimicrobial catheters, and connected medical technologies is expected to strengthen the global IV Equipment Market in the coming years.

Global IV Equipment Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: More than 77% of healthcare facilities continue increasing investment in advanced intravenous therapy equipment to improve patient safety and treatment efficiency.
  • Major Market Restraint: Around 43% of healthcare providers identify high equipment costs and maintenance requirements as significant operational challenges.
  • Emerging Trends: Approximately 68% of newly introduced IV equipment integrates smart monitoring, wireless connectivity, and automated drug delivery technologies.
  • Regional Leadership: North America accounts for approximately 39% of market demand, followed by Europe with 28%, Asia-Pacific with 25%, and Middle East & Africa with 8%.
  • Competitive Landscape: Nearly 72% of global market demand is supplied by established medical device manufacturers with extensive healthcare distribution networks.
  • Market Segmentation: Infusion Pump contributes approximately 47% of market demand, followed by Catheter and Solution and Blood Administration Set.
  • Recent Development: Around 64% of recent product launches emphasize smart infusion technology, enhanced patient safety, and improved infection prevention features.

The IV Equipment Market Trends indicate increasing adoption of smart infusion pumps, wireless monitoring technologies, and automated medication delivery systems. Approximately 69% of hospitals continue investing in intelligent infusion platforms capable of reducing medication errors and improving clinical workflow efficiency. Around 58% of healthcare providers prioritize closed-system intravenous equipment and needle-free technologies to strengthen infection prevention. Rising digital healthcare adoption continues accelerating technological innovation across the market.

Manufacturers continue focusing on improving patient safety, precision drug delivery, and device interoperability. Nearly 63% of newly introduced IV equipment features intelligent dosing software, touchscreen interfaces, and integrated alarm systems. Around 57% of healthcare institutions continue replacing conventional intravenous devices with advanced digital systems supporting real-time monitoring and electronic medical record integration. Continuous innovation in intravenous therapy technologies continues supporting IV Equipment Market Growth worldwide.

IV Equipment Market Dynamics

DRIVER

"Increasing demand for safe and efficient intravenous therapy"

The primary driver of the IV Equipment Market is increasing demand for accurate medication delivery across hospitals, homecare, and ambulatory healthcare facilities. More than 75% of inpatient treatments require intravenous administration for fluids, medications, blood products, or nutritional support. Approximately 68% of healthcare providers continue adopting advanced infusion technologies that improve treatment accuracy and reduce medication errors. Growing prevalence of chronic diseases, aging populations, and expanding healthcare services continue supporting long-term market expansion.

RESTRAINTS

"High equipment costs and regulatory compliance requirements"

High procurement costs and stringent medical device regulations remain significant restraints affecting the IV Equipment Market. Approximately 45% of healthcare providers identify equipment maintenance and regulatory compliance as key purchasing considerations. Around 42% of smaller healthcare facilities experience financial challenges while upgrading intravenous therapy infrastructure. Continuous regulatory updates and quality assurance requirements continue influencing market development.

OPPORTUNITY

"Expansion of home healthcare and smart infusion technologies"

The IV Equipment Market presents significant opportunities through increasing home-based healthcare, digital monitoring, and intelligent infusion systems. Approximately 62% of medical device manufacturers continue investing in portable infusion technologies supporting outpatient and homecare treatments. Around 57% of healthcare providers prioritize connected IV equipment that improves remote monitoring and clinical decision-making. Growing demand for personalized healthcare continues creating attractive long-term business opportunities.

CHALLENGE

"Maintaining patient safety while reducing medication errors"

Ensuring safe intravenous therapy while minimizing medication errors remains a major challenge within the IV Equipment Market. Approximately 54% of healthcare organizations continue investing in smart infusion technologies, staff training, and automated safety systems to improve treatment accuracy. Around 49% of manufacturers prioritize advanced software validation and device reliability to strengthen patient safety. Continuous innovation remains essential for sustaining long-term market competitiveness.

IV Equipment Market Segmentation

The IV Equipment Market is segmented by type and application to address increasing demand for reliable intravenous therapy across healthcare settings. Infusion Pump remains the leading segment because of its widespread use in controlled drug delivery and fluid administration, while Catheters and Solution and Blood Administration Sets continue supporting essential clinical procedures. More than 82% of healthcare providers continue investing in advanced IV equipment to improve treatment efficiency, patient safety, and clinical outcomes.

Global IV Equipment Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Type

Infusion Pump: Infusion Pump leads the IV Equipment Market with approximately 47% market share owing to increasing demand for precise medication delivery, fluid management, and critical care applications. More than 76% of hospitals continue utilizing smart infusion pumps equipped with programmable dosing systems, automated alerts, and electronic medical record integration to improve treatment safety and operational efficiency.

Catheter: Catheter accounts for approximately 31% of the IV Equipment Market because of its essential role in intravenous therapy, emergency care, and long-term medication administration. Approximately 69% of inpatient intravenous procedures continue utilizing advanced catheter systems designed to reduce infection risks, improve patient comfort, and enhance clinical performance.

Solution and Blood Administration Set: Solution and Blood Administration Set contributes nearly 22% of the IV Equipment Market due to increasing demand for safe fluid delivery, blood transfusion, and intravenous medication administration. Around 66% of healthcare facilities continue utilizing high-quality administration sets equipped with flow regulators, filters, and safety connectors to improve treatment accuracy and infection control.

By Application

Hospitals & Clinics: Hospitals & Clinics account for approximately 66% of the IV Equipment Market owing to increasing inpatient admissions, surgical procedures, emergency care, and chronic disease treatment. More than 78% of intravenous therapies are administered within hospitals and clinical healthcare facilities, making this the largest application segment.

Homecare: Homecare contributes approximately 20% of the IV Equipment Market as portable infusion systems and home-based intravenous therapy continue expanding for chronic disease management and long-term treatment. Around 61% of patients requiring extended infusion therapy increasingly receive treatment through home healthcare services supported by portable IV equipment.

Ambulatory Care Center: Ambulatory Care Center represents approximately 14% of the IV Equipment Market due to increasing outpatient procedures, same-day surgeries, and minimally invasive treatments. Nearly 58% of ambulatory care centers continue investing in compact, efficient, and smart IV equipment to improve workflow efficiency, patient safety, and treatment quality.

IV Equipment Market Regional Outlook

The IV Equipment Market continues expanding globally due to increasing healthcare expenditure, growing chronic disease prevalence, rising surgical procedures, and continuous technological advancements in intravenous therapy. North America accounts for approximately 39% of the global market, followed by Europe with 28%, Asia-Pacific with 25%, and Middle East & Africa with 8%. Continuous investment in hospital modernization, digital healthcare infrastructure, and smart infusion technologies continues supporting market growth across all major regions.

Global IV Equipment Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America accounts for approximately 39% of the IV Equipment Market owing to advanced healthcare infrastructure, increasing adoption of smart infusion systems, and growing demand for patient safety technologies. More than 74% of hospitals continue utilizing intelligent IV equipment to improve medication accuracy, infection prevention, and clinical workflow efficiency.

Approximately 66% of healthcare providers continue investing in connected infusion pumps, advanced catheter systems, and automated medication delivery technologies. Strong regulatory standards and continuous healthcare technology innovation continue supporting long-term regional market expansion.

Europe

Europe represents nearly 28% of the IV Equipment Market, supported by modern healthcare systems, increasing surgical procedures, and expanding elderly population. Around 69% of hospitals continue upgrading intravenous therapy equipment to improve patient safety, regulatory compliance, and treatment efficiency.

Approximately 58% of healthcare institutions continue investing in advanced infusion technologies, infection control devices, and digital patient monitoring systems. Continuous healthcare modernization and medical technology innovation continue strengthening market development throughout Europe.

Asia-Pacific

Asia-Pacific accounts for approximately 25% of the IV Equipment Market owing to expanding healthcare infrastructure, increasing hospital admissions, and rising government healthcare investments. Nearly 72% of newly established hospitals continue procuring advanced intravenous therapy equipment to improve treatment quality and operational efficiency.

Around 64% of regional healthcare providers continue investing in portable infusion systems, smart pumps, and advanced blood administration devices. Growing healthcare access, increasing chronic disease treatment, and expanding medical infrastructure continue creating significant opportunities throughout the region.

Middle East & Africa

Middle East & Africa contribute approximately 8% of the IV Equipment Market through expanding healthcare infrastructure, hospital development, and increasing investment in medical technologies. Around 49% of healthcare facilities continue modernizing intravenous therapy equipment to improve patient care and treatment reliability.

Approximately 45% of regional healthcare investments focus on hospital expansion, advanced infusion systems, and improved emergency care capabilities. Growing healthcare expenditure and expanding access to quality medical services continue supporting future market growth across the region.

List of top IV Equipment Market Companies

  • BECTON, DICKINSON AND COMPANY
  • B. BRAUN MELSUNGEN
  • BAXTER INTERNATIONAL
  • FRESENIUS SE
  • ICU MEDICAL
  • SMITHS MEDICAL
  • C.R. BARD
  • Terumo
  • MOOG
  • ANGIODYNAMICS

Top Two Companies with Highest Share

  • BECTON, DICKINSON AND COMPANY: Approximately 23% market share supported by its comprehensive intravenous therapy portfolio, global healthcare presence, and strong innovation in infusion technologies.
  • BAXTER INTERNATIONAL: Approximately 19% market share driven by its advanced infusion pumps, IV administration systems, and extensive worldwide hospital distribution network.

Investment Analysis and Opportunities

Investment in the IV Equipment Market continues increasing as healthcare providers modernize clinical infrastructure and manufacturers expand advanced intravenous therapy technologies. Approximately 68% of recent investments focus on smart infusion pumps, automated medication delivery systems, wireless monitoring, and infection prevention technologies. Around 61% of medical device manufacturers continue investing in research and development to improve device accuracy, patient safety, and operational efficiency. Growing demand for advanced intravenous therapy across hospitals, ambulatory care centers, and homecare settings continues creating attractive investment opportunities worldwide.

Emerging opportunities continue expanding through home healthcare, digital health integration, remote patient monitoring, and portable infusion technologies. Nearly 59% of manufacturers prioritize intelligent IV systems featuring wireless connectivity, predictive maintenance, and electronic medical record integration. Around 55% of healthcare organizations continue investing in advanced intravenous equipment to improve clinical outcomes, reduce medication errors, and optimize healthcare workflows. Continuous technological innovation and expanding healthcare infrastructure continue supporting long-term business opportunities across the global IV Equipment Market.

New Products Development

Manufacturers operating in the IV Equipment Market continue introducing next-generation intravenous therapy solutions featuring smart infusion technologies, wireless connectivity, advanced safety software, and enhanced infection prevention systems. Approximately 69% of newly launched IV devices emphasize automated drug delivery, real-time monitoring, programmable dosing, and intelligent alarm management to improve patient safety and clinical efficiency. Around 63% of manufacturers continue investing in portable infusion pumps, needle-free connectors, antimicrobial catheter technologies, and digital monitoring platforms to reduce medication errors and improve treatment outcomes. Nearly 58% of newly developed IV equipment supports electronic medical record integration, remote device management, and predictive maintenance, enabling healthcare providers to improve workflow efficiency while delivering accurate and reliable intravenous therapy across hospitals, ambulatory care centers, and home healthcare environments.

Product innovation also focuses on patient comfort, regulatory compliance, and sustainable medical device manufacturing. Approximately 61% of manufacturers continue developing lightweight infusion systems, disposable safety components, and environmentally responsible production processes to improve operational efficiency and reduce healthcare waste. Around 56% of suppliers prioritize closed-system IV administration sets, advanced filtration technologies, and precision flow control mechanisms that minimize infection risks while improving medication delivery accuracy. Nearly 53% of recently introduced intravenous therapy products incorporate touchscreen interfaces, intelligent dose calculation software, enhanced battery performance, and cloud-based monitoring capabilities, supporting safer treatment, simplified clinical operations, and improved healthcare outcomes across diverse medical environments.

Five Recent Developments (2023-2025)

  • BECTON, DICKINSON AND COMPANY: In 2025, the company expanded its smart infusion and vascular access portfolio with enhanced patient safety and digital medication management capabilities.
  • BAXTER INTERNATIONAL: During 2025, Baxter strengthened its infusion therapy solutions through continued investment in connected infusion systems and advanced medication delivery technologies.
  • B. BRAUN MELSUNGEN: In 2024, the company introduced upgraded infusion management solutions designed to improve dosing accuracy and hospital workflow efficiency.
  • ICU MEDICAL: During 2024, ICU Medical expanded its intravenous therapy product portfolio with enhanced infusion safety technologies and advanced administration systems.
  • Terumo: In 2023, Terumo strengthened its vascular access and infusion device portfolio through new product enhancements supporting safer intravenous therapy procedures.

Report Coverage of IV Equipment Market

The IV Equipment Market Report provides comprehensive analysis of market trends, market size, market share, market growth, competitive landscape, technological developments, regional outlook, and strategic business opportunities influencing global industry expansion. The report evaluates equipment types, healthcare applications, product innovation, technological advancements, manufacturing capabilities, and competitive positioning using percentage-based industry indicators without presenting revenue or CAGR values. Approximately 66% of the analysis focuses on infusion pumps, catheter technologies, solution and blood administration sets, smart infusion systems, patient safety technologies, and digital healthcare integration supporting future market development.

The IV Equipment Market Research Report also delivers detailed assessment of regional healthcare infrastructure, leading manufacturers, product development strategies, regulatory requirements, and emerging business opportunities. Approximately 61% of the report emphasizes increasing investment in smart infusion technologies, wireless monitoring systems, infection prevention solutions, portable intravenous devices, and healthcare digitalization supporting long-term market expansion. The report further analyzes competitive strategies, hospital modernization, home healthcare adoption, technological innovation, and distribution networks, making it a valuable business resource for medical device manufacturers, healthcare providers, distributors, investors, procurement professionals, and industry decision-makers.

The IV Equipment Market continues experiencing steady expansion as healthcare providers increasingly prioritize accurate medication delivery, patient safety, and digital healthcare integration. Approximately 72% of hospitals continue investing in advanced intravenous therapy systems capable of improving clinical efficiency and reducing medication errors. More than 67% of manufacturers continue expanding research and development activities focused on smart infusion technologies, portable devices, and infection prevention solutions. Continuous innovation in intravenous therapy equipment continues supporting market growth across hospitals, ambulatory care centers, and home healthcare environments.

Technological advancement remains another major contributor to future market development. Around 64% of manufacturers continue investing in artificial intelligence, wireless communication technologies, predictive maintenance systems, and intelligent infusion software to improve operational performance. Approximately 58% of healthcare organizations continue replacing conventional intravenous equipment with connected smart devices capable of supporting electronic medical records, automated dosing, and remote monitoring. Growing healthcare infrastructure investment, increasing chronic disease treatment, expanding homecare services, and continuous advancement in medical technology are expected to create substantial opportunities for manufacturers, distributors, investors, healthcare providers, and technology companies operating within the global IV Equipment Market.

IV Equipment Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 17535.31 Million in 2026

Market Size Value By

USD 28562.18 Million by 2035

Growth Rate

CAGR of 5.57% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Infusion Pump
  • Catheter
  • Solution and Blood Administration Set

By Application :

  • Hospitals & Clinics
  • Homecare
  • Ambulatory Care Center

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global IV Equipment Market is expected to reach USD 28562.18 Million by 2035.

The IV Equipment Market is expected to exhibit a CAGR of 5.57% by 2035.

BECTON, DICKINSON AND COMPANY, B. BRAUN MELSUNGEN, BAXTER INTERNATIONAL, FRESENIUS SE, ICU MEDICAL, SMITHS MEDICAL, C.R. BARD, Terumo, MOOG, ANGIODYNAMICS

In 2026, the IV Equipment Market is estimated at USD 17535.31 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified